ArticleJournal of comparative effectiveness research2026
Most-Favored-Nation pricing meets Joint Clinical Assessment: early evidence of compounding pressure on European drug launches.
Sreeram V Ramagopalan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.